Skip Nav Destination
Issues
1 May 2021
-
Cover Image
Cover Image
The cover shows an on-treatment biopsy taken from a patient with metastatic microsatellite stable colorectal cancer treated with combined PD-L1/CTLA-4 inhibition and targeted radiotherapy to a liver metastasis. Multiplex immunofluorescence staining demonstrates increased infiltration of CD8+(white)/PD-1+(green)/Ki-67+(red) cells with treatment. Cytokeratin (purple) highlights malignant cells. For details, see the article by Monjazeb and colleagues on page 2470 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Drug Updates
FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
Sonia Singh; Adnan A. Jaigirdar; Flora Mulkey; Joyce Cheng; Salaheldin S. Hamed; Yangbing Li; Jiang Liu; Hong Zhao; Anwar Goheer; Whitney S. Helms; Xing Wang; Rajiv Agarwal; Rajan Pragani; Kwadwo Korsah; Shenghui Tang; John Leighton; Atiqur Rahman; Julia A. Beaver; Richard Pazdur; Marc R. Theoret; Harpreet Singh
Review
Perspectives
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement
Edward S. Kim; Thomas S. Uldrick; Caroline Schenkel; Suanna S. Bruinooge; R. Donald Harvey; Allison Magnuson; Alexander Spira; James L. Wade; Mark D. Stewart; Diana Merino Vega; Julia A. Beaver; Andrea M. Denicoff; Gwynn Ison; S. Percy Ivy; Suzanne George; Raymond P. Perez; Patricia A. Spears; William D. Tap; Richard L. Schilsky
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group
R. Donald Harvey; Kathryn F. Mileham; Vishal Bhatnagar; Jamie R. Brewer; Atiqur Rahman; Cassadie Moravek; Andrew S. Kennedy; Elizabeth A. Ness; E. Claire Dees; S. Percy Ivy; Scot W. Ebbinghaus; Caroline Schenkel; Thomas S. Uldrick
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO–Friends of Cancer Research Prior Therapies Work Group
Raymond U. Osarogiagbon; Diana Merino Vega; Lola Fashoyin-Aje; Suparna Wedam; Gwynn Ison; Sol Atienza; Peter De Porre; Tithi Biswas; Jamie N. Holloway; David S. Hong; Madison M. Wempe; Richard L. Schilsky; Edward S. Kim; James L. Wade, III
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group
Alexander I. Spira; Mark D. Stewart; Suzanne Jones; Elaine Chang; Anitra Fielding; Nicole Richie; Laura S. Wood; Michael A. Thompson; Lee Jones; Abhilasha Nair; Brandon A. Mahal; David E. Gerber
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group
Allison Magnuson; Suanna S. Bruinooge; Harpreet Singh; Keith D. Wilner; Shadia Jalal; Stuart M. Lichtman; Paul G. Kluetz; Gary H. Lyman; Heidi D. Klepin; Mark E. Fleury; Brad Hirsch; Allen Melemed; Fernanda I. Arnaldez; Upal Basu Roy; Caroline Schenkel; Shimere Sherwood; Elizabeth Garrett-Mayer
Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations
R. Donald Harvey; Suanna S. Bruinooge; Li Chen; Elizabeth Garrett-Mayer; Whitney Rhodes; Edward Stepanski; Thomas S. Uldrick; Gwynn Ison; Sean Khozin; Wendy S. Rubinstein; Caroline Schenkel; Robert S. Miller; George A. Komatsoulis; Richard L. Schilsky; Edward S. Kim
Clinical Trials: Targeted Therapy
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
Thomas W. Flaig; Catherine M. Tangen; Siamak Daneshmand; Ajjai Alva; Seth P. Lerner; M. Scott Lucia; David J. McConkey; Dan Theodorescu; Amir Goldkorn; Matthew I. Milowsky; Rick Bangs; Gary R. MacVicar; Bruno R. Bastos; Jared S. Fowles; Daniel L. Gustafson; Melissa Plets; Ian M. Thompson, Jr
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study
Mariko D. DeWire; Christine Fuller; Olivia Campagne; Tong Lin; Haitao Pan; Tina Young Poussaint; Patricia A. Baxter; Eugene I. Hwang; Andrew Bukowinski; Kathleen Dorris; Lindsey Hoffman; Angela J. Waanders; Matthias A. Karajannis; Clinton F. Stewart; Arzu Onar-Thomas; Maryam Fouladi; Ira J. Dunkel
An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer
Ning Li; Hualei Bu; Jihong Liu; Jianqing Zhu; Qi Zhou; Li Wang; Rutie Yin; Xiaohua Wu; Shuzhong Yao; Kangsheng Gu; Hui Zhang; Guiling Li; Hongming Pan; Qiang Wu; Ruifang An; Xinfeng Yang; Yaping Zhu; Xiaoping Wan; Wei Duan; Jianping Xiong; Hongyan Guo; Ge Lou; Jing Wang; Wenjing Hu; Xin Zhang; Yuanguang Meng; Ben Zhang; Yuting Wang; Quanren Wang; Lingying Wu
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non–Small Cell Lung Cancer
Michael Skwarski; Daniel R. McGowan; Elizabeth Belcher; Francesco Di Chiara; Dionisios Stavroulias; Mark McCole; Jennifer L. Derham; Kwun-Ye Chu; Eugene Teoh; Jagat Chauhan; Dawn O’Reilly; Benjamin H.L. Harris; Philip S. Macklin; Joshua A. Bull; Marcus Green; Gonzalo Rodriguez-Berriguete; Remko Prevo; Lisa K. Folkes; Leticia Campo; Petra Ferencz; Paula L. Croal; Helen Flight; Cathy Qi; Jane Holmes; James P.B. O’Connor; Fergus V. Gleeson; W. Gillies McKenna; Adrian L. Harris; Daniel Bulte; Francesca M. Buffa; Ruth E. Macpherson; Geoff S. Higgins
Clinical Trials: Immunotherapy
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Arta M. Monjazeb; Anita Giobbie-Hurder; Ana Lako; Emily M. Thrash; Ryan C. Brennick; Katrina Z. Kao; Claire Manuszak; Ryan D. Gentzler; Anteneh Tesfaye; Salma K. Jabbour; Olatunji B. Alese; Osama E. Rahma; James M. Cleary; Elad Sharon; Harvey J. Mamon; May Cho; Howard Streicher; Helen X. Chen; Mansoor M. Ahmed; Adrian Mariño-Enríquez; Seunghee Kim-Schulze; Sacha Gnjatic; Emanual Maverakis; Alina I. Marusina; Alexander A. Merleev; Mariano Severgnini; Kathleen L. Pfaff; James Lindsay; Jason L. Weirather; Srinika Ranasinghe; Alexander Spektor; Scott J. Rodig; F. Stephen Hodi; Jonathan D. Schoenfeld
Author Choice
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy
Melinda L. Telli; Hiroshi Nagata; Irene Wapnir; Chaitanya R. Acharya; Kaitlin Zablotsky; Bernard A. Fox; Carlo B. Bifulco; Shawn M. Jensen; Carmen Ballesteros-Merino; Mai Hope Le; Robert H. Pierce; Erica Browning; Reneta Hermiz; Lauren Svenson; Donna Bannavong; Kim Jaffe; Jendy Sell; Kellie Malloy Foerter; David A. Canton; Christopher G. Twitty; Takuya Osada; H. Kim Lyerly; Erika J. Crosby
Precision Medicine and Imaging
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers
Kelly L. Harms; Lili Zhao; Bryan Johnson; Xiaoming Wang; Shannon Carskadon; Nallasivam Palanisamy; Daniel R. Rhodes; Rahul Mannan; Josh N. Vo; Jae Eun Choi; May P. Chan; Douglas R. Fullen; Rajiv M. Patel; Javed Siddiqui; Vincent T. Ma; Steven Hrycaj; Scott A. McLean; Tasha M. Hughes; Christopher K. Bichakjian; Scott A. Tomlins; Paul W. Harms
Author Choice
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Paolo Manca; Salvatore Corallo; Adele Busico; Sara Lonardi; Francesca Corti; Carlotta Antoniotti; Letizia Procaccio; Matteo Clavarezza; Valeria Smiroldo; Gianluca Tomasello; Roberto Murialdo; Andrea Sartore-Bianchi; Patrizia Racca; Filippo Pagani; Giovanni Randon; Antonia Martinetti; Elisa Sottotetti; Federica Palermo; Federica Perrone; Elena Tamborini; Michele Prisciandaro; Alessandra Raimondi; Maria Di Bartolomeo; Federica Morano; Filippo Pietrantonio
Author Choice
Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study
Yoshinori Kagawa; Elena Elez; Jesús García-Foncillas; Hideaki Bando; Hiroya Taniguchi; Ana Vivancos; Kiwamu Akagi; Ariadna García; Tadamichi Denda; Javier Ros; Tomohiro Nishina; Iosune Baraibar; Yoshito Komatsu; Davide Ciardiello; Eiji Oki; Toshihiro Kudo; Takeshi Kato; Takeharu Yamanaka; Josep Tabernero; Takayuki Yoshino
High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
Shounak Majumder; William R. Taylor; Patrick H. Foote; Calise K. Berger; Chung Wah Wu; Douglas W. Mahoney; William R. Bamlet; Kelli N. Burger; Neil Postier; Jaime de la Fuente; Karen A. Doering; Graham P. Lidgard; Hatim T. Allawi; Gloria M. Petersen; Suresh T. Chari; David A. Ahlquist; John B. Kisiel
Translational Cancer Mechanisms and Therapy
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
Lara Paracchini; Luca Beltrame; Tommaso Grassi; Alessia Inglesi; Robert Fruscio; Fabio Landoni; Davide Ippolito; Martina Delle Marchette; Mariachiara Paderno; Marco Adorni; Marta Jaconi; Chiara Romualdi; Maurizio D'Incalci; Giulia Siravegna; Sergio Marchini
Author Choice
Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma
Jad Chahoud; Frederico O. Gleber-Netto; Barrett Z. McCormick; Priya Rao; Xin Lu; Ming Guo; Maggaret B. Morgan; Randy A. Chu; Magaly Martinez-Ferrer; Agda Karina Eterovic; Curtis R. Pickering; Curtis A. Pettaway
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Fyza Y. Shaikh; James R. White; Joell J. Gills; Taiki Hakozaki; Corentin Richard; Bertrand Routy; Yusuke Okuma; Mykhaylo Usyk; Abhishek Pandey; Jeffrey S. Weber; Jiyoung Ahn; Evan J. Lipson; Jarushka Naidoo; Drew M. Pardoll; Cynthia L. Sears
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer
Bruno V. Sinn; Sibylle Loibl; Claus A. Hanusch; Dirk-Michael Zahm; Hans-Peter Sinn; Michael Untch; Karsten Weber; Thomas Karn; Clemens Becker; Frederik Marmé; Wolfgang D. Schmitt; Volkmar Müller; Christian Schem; Denise Treue; Elmar Stickeler; Frederik Klauschen; Nicole Burchardi; Jenny Furlanetto; Marion van Mackelenbergh; Peter A. Fasching; Andreas Schneeweiss; Carsten Denkert
Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification
Sidsel C. Lindgaard; Zsófia Sztupinszki; Emil Maag; Inna M. Chen; Astrid Z. Johansen; Benny V. Jensen; Stig E. Bojesen; Dorte L. Nielsen; Carsten P. Hansen; Jane P. Hasselby; Kaspar R. Nielsen; Zoltan Szallasi; Julia S. Johansen
KRASG12C Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma
Gregory D. Jones; Raul Caso; Kay See Tan; Brooke Mastrogiacomo; Francisco Sanchez-Vega; Yuan Liu; James G. Connolly; Yonina R. Murciano-Goroff; Matthew J. Bott; Prasad S. Adusumilli; Daniela Molena; Gaetano Rocco; Valerie W. Rusch; Smita Sihag; Sandra Misale; Rona Yaeger; Alexander Drilon; Kathryn C. Arbour; Gregory J. Riely; Neal Rosen; Piro Lito; Haiying Zhang; David C. Lyden; Charles M. Rudin; David R. Jones; Bob T. Li; James M. Isbell
Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas
Amir Momeni-Boroujeni; Wissam Dahoud; Chad M. Vanderbilt; Sarah Chiang; Rajmohan Murali; Eric V. Rios-Doria; Kaled M. Alektiar; Carol Aghajanian; Nadeem R. Abu-Rustum; Marc Ladanyi; Lora H. Ellenson; Britta Weigelt; Robert A. Soslow
G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
Gregory M. Kelly; Fares Al-Ejeh; Robert McCuaig; Francesco Casciello; Nabilah Ahmad Kamal; Blake Ferguson; Antonia L. Pritchard; Sayed Ali; Ines P. Silva; James S. Wilmott; Georgina V. Long; Richard A. Scolyer; Sudha Rao; Nicholas K. Hayward; Frank Gannon; Jason S. Lee
Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer
Xian Wang; Jamunarani Veeraraghavan; Chia-Chia Liu; Xixi Cao; Lanfang Qin; Jin-Ah Kim; Ying Tan; Suet Kee Loo; Yiheng Hu; Ling Lin; Sanghoon Lee; Martin J. Shea; Tamika Mitchell; Shunqiang Li; Matthew J. Ellis; Susan G. Hilsenbeck; Rachel Schiff; Xiao-Song Wang
Corrections
Correction: A Virus-infected, Reprogrammed Somatic Cell–derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic Cancer
Shuangshuang Lu; Zhe Zhang; Pan Du; Louisa S. Chard; Wenli Yan; Margueritte El Khouri; Zhizhong Wang; Zhongxian Zhang; Yongchao Chu; Dongling Gao; Qinxian Zhang; Lirong Zhang; Ai Nagano; Jun Wang; Claude Chelala; Jing Liu; Jiekai Chen; Pentao Liu; Yunshu Dong; Shengdian Wang; Xiaozhu Li; Jianzeng Dong; Nick R. Lemoine; Duanqing Pei; Yaohe Wang
Correction: PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial–Mesenchymal Transition
Xin Chen; Ri-Xin Chen; Wen-Su Wei; Yong-Hong Li; Zi-Hao Feng; Lei Tan; Jie-Wei Chen; Gang-Jun Yuan; Si-Liang Chen; Sheng-Jie Guo; Kang-Hua Xiao; Zhuo-Wei Liu; Jun-Hang Luo; Fang-Jian Zhou; Dan Xie
Editor’s Notes
Editor's Note: Epigenetic Modifications of RASSF1A Gene through Chromatin Remodeling in Prostate Cancer
Ken Kawamoto; Steven T. Okino; Robert F. Place; Shinji Urakami; Hiroshi Hirata; Nobuyuki Kikuno; Toshifumi Kawakami; Yuichiro Tanaka; Deepa Pookot; Zhong Chen; Shahana Majid; Hideki Enokida; Masayuki Nakagawa; Rajvir Dahiya
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds